Correlation Between Eventide Healthcare and Tekla Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eventide Healthcare and Tekla Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eventide Healthcare and Tekla Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eventide Healthcare Life and Tekla Healthcare Opportunities, you can compare the effects of market volatilities on Eventide Healthcare and Tekla Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eventide Healthcare with a short position of Tekla Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eventide Healthcare and Tekla Healthcare.

Diversification Opportunities for Eventide Healthcare and Tekla Healthcare

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Eventide and Tekla is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Eventide Healthcare Life and Tekla Healthcare Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tekla Healthcare Opp and Eventide Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eventide Healthcare Life are associated (or correlated) with Tekla Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tekla Healthcare Opp has no effect on the direction of Eventide Healthcare i.e., Eventide Healthcare and Tekla Healthcare go up and down completely randomly.

Pair Corralation between Eventide Healthcare and Tekla Healthcare

Assuming the 90 days horizon Eventide Healthcare Life is expected to under-perform the Tekla Healthcare. In addition to that, Eventide Healthcare is 1.81 times more volatile than Tekla Healthcare Opportunities. It trades about -0.18 of its total potential returns per unit of risk. Tekla Healthcare Opportunities is currently generating about 0.1 per unit of volatility. If you would invest  1,917  in Tekla Healthcare Opportunities on February 28, 2024 and sell it today you would earn a total of  97.00  from holding Tekla Healthcare Opportunities or generate 5.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Eventide Healthcare Life  vs.  Tekla Healthcare Opportunities

 Performance 
       Timeline  
Eventide Healthcare Life 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eventide Healthcare Life has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's technical indicators remain fairly strong which may send shares a bit higher in June 2024. The current disturbance may also be a sign of long term up-swing for the fund investors.
Tekla Healthcare Opp 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Tekla Healthcare Opportunities are ranked lower than 7 (%) of all funds and portfolios of funds over the last 90 days. Even with relatively invariable technical indicators, Tekla Healthcare is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Eventide Healthcare and Tekla Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eventide Healthcare and Tekla Healthcare

The main advantage of trading using opposite Eventide Healthcare and Tekla Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eventide Healthcare position performs unexpectedly, Tekla Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tekla Healthcare will offset losses from the drop in Tekla Healthcare's long position.
The idea behind Eventide Healthcare Life and Tekla Healthcare Opportunities pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance